Continued treatment for early and mild-moderate Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial provides continued access to an investigational drug (TRx0237) for people with early or mild-moderate Alzheimer's disease. It aims to see if long-term use is safe and beneficial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage or mild-moderate Alzheimer's disease, confirmed by a memory test.
- You can travel to the clinic for scheduled visits.
- You have a study partner (like a family member or friend) who can accompany you to visits and report on your condition.
- You are not taking part in another investigational drug trial.
- If you are a woman who can have children, you must use birth control during the trial and for a period before and after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug for Alzheimer's called NTRX-07. It aims to see if it can slow memory decline for people with mild to moderate Alzheimer's.
This program provides access to an investigational drug called TB006 for people with Alzheimer's disease or related dementias who have run out of standard treatment options. It aims to see if the drug is safe and helpful in a real-world setting.
This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This early-stage trial tests a new medicine called GSM-779690T in healthy volunteers to see how safe it is and how the body handles it. Participating could help determine if the medicine is worth testing in people with certain conditions later.
This trial tests a treatment targeting tau protein buildup in the brain for people with early Alzheimer's. You may join if you have memory or thinking changes but are still living independently, and brain scans show both amyloid and tau clumps.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.